Novel domain-selective ACE-inhibiting activity of synthetic growth hormone secretagogues

Pharmacological Research

Volumn 66, Issue 4, 2012, Pages 317-324

  Torsello, Antonio ^a   Bresciani, Elena ^a   Ravelli, Monica ^a   Rizzi, Laura ^a   Bulgarelli, Ilaria ^a   Ricci, Giorgio ^b   Ghiazza, Barbara ^c   Del Puppo, Marina ^a   Mainini, Veronica ^a   Omeljaniuk, Robert J ^d   Tamiazzo, Laura ^a   Mancia, Giuseppe ^a   Magni, Fulvio ^a   Locatelli, Vittorio ^a  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b Nursing Home RSA Villa San Clemente Gruppo Segesta   (Italy)

^c Nursing Home RSA Monzini   (Italy)

^d LAKEHEAD UNIVERSITY   (Canada)

Author keywords

Amyloid; ACE inhibitors; Alzheimer's dementia; EP80317; Ghrelin; Vascular dementia

Indexed keywords

ALDOSTERONE; AMYLOID BETA PROTEIN; ANGIOTENSIN; CD36 ANTIGEN; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; DESACYL GHRELIN; DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRIL; EP 80317; GHRELIN; GHRELIN RECEPTOR; GROWTH HORMONE SECRETAGOGUE; HEXARELIN; HISTIDYL DEXTRO TRYPTOPHYLALANYLTRYPTOPHYL DEXTRO PHENYLALANYLLYSINAMIDE; IBUTAMOREN; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RENIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ACE GENE; AGED; ALZHEIMER DISEASE; ARTICLE; BINDING AFFINITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG SELECTIVITY; ENZYME INHIBITION; GENE; GENETIC POLYMORPHISM; HUMAN; IN VITRO STUDY; MULTIINFARCT DEMENTIA; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN CLEAVAGE; PROTEIN DOMAIN; PROTEIN METABOLISM; RECEPTOR BINDING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CYTOKINES; DEMENTIA, VASCULAR; GHRELIN; HUMANS; OLIGOPEPTIDES; PEPTIDYL-DIPEPTIDASE A; PROTEIN STRUCTURE, TERTIARY; RABBITS; RECEPTORS, GHRELIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 84864998047     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2012.06.006     Document Type: Article

References (52)

1. V. Locatelli, G. Rossoni, F. Schweiger, A. Torsello, V. De Gennaro Colonna, and M. Bernareggi Growth hormone-independent cardioprotective effects of hexarelin in the rat Endocrinology 140 1999 4024 4031 (Pubitemid 30647097)
2. F. Broglio, F. Guarracino, A. Benso, C. Gottero, F. Prodam, and R. Granata Effects of acute hexarelin administration on cardiac performance in patients with coronary artery disease during by-pass surgery European Journal of Pharmacology 448 2002 193 200 (Pubitemid 34874587)
3. A. Torsello, E. Bresciani, G. Rossoni, R. Avallone, G. Tulipano, and D. Cocchi Ghrelin plays a minor role in the physiological control of cardiac function in the rat Endocrinology 144 2003 1787 1792 (Pubitemid 36543316)
4. M. Kojima, H. Hosoda, Y. Date, M. Nakazato, H. Matsuo, and K. Kangawa Ghrelin is a growth-hormone-releasing acylated peptide from stomach Nature 402 1999 656 660 (Pubitemid 129516334)
5. C.Y. Chen, A. Asakawa, M. Fujimiya, S.D. Lee, and A. Inui Ghrelin gene products and the regulation of food intake and gut motility Pharmacological Review 61 2009 430 481
6. M.J. Kleinz, J.J. Maguire, J.N. Skepper, and A.P. Davenport Functional and immunocytochemical evidence for a role of ghrelin and des-octanoyl ghrelin in the regulation of vascular tone in man Cardiovascular Research 69 2006 227 235 (Pubitemid 41814824)
7. H. Okumura, N. Nagaya, M. Enomoto, E. Nakagawa, H. Oya, and K. Kangawa Vasodilatory effect of ghrelin, an endogenous peptide from the stomach Journal of Cardiovascular Pharmacology 39 2002 779 783 (Pubitemid 34538806)
8. N. Nagaya, K. Miyatake, M. Uematsu, H. Oya, W. Shimizu, and H. Hosoda Hemodynamic, renal, and hormonal effects of ghrelin infusion in patients with chronic heart failure Journal of Clinical Endocrinology and Metabolism 86 2001 5854 5859 (Pubitemid 33152634)
9. G.H. Li, J.Z. Wan, G.W. Le, and Y.H. Shi Novel angiotensin I-converting enzyme inhibitory peptides isolated from alcalase hydrolysate of mung bean protein Journal of Peptide Science 12 2006 509 514
10. F. Soubrier, F. Alhenc-Gelas, C. Hubert, J. Allegrini, M. John, and G. Tregear Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning Proceedings of the National Academy of Sciences of the United States of America 85 1988 9386 9390 (Pubitemid 19027137)
11. D. Georgiadis, F. Beau, B. Czarny, J. Cotton, A. Yiotakis, and V. Dive Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors Circulation Research 93 2003 148 154 (Pubitemid 36919702)
12. H. Katzov, A.M. Bennet, P. Kehoe, B. Wiman, M. Gatz, and K. Blennow A cladistic model of ACE sequence variation with implications for myocardial infarction, Alzheimer disease and obesity Human Molecular Genetics 13 2004 2647 2657 (Pubitemid 39485413)
13. D.J. Lehmann, M. Cortina-Borja, D.R. Warden, A.D. Smith, K. Sleegers, and J.A. Prince Large meta-analysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer's disease American Journal of Epidemiology 162 2005 305 317 (Pubitemid 41389712)
14. R.N. Kalaria, and P. Hedera Differential degeneration of the cerebral microvasculature in Alzheimer's disease Neuroreport 6 1995 477 480
15. J. Naslund, V. Haroutunian, R. Mohs, K.L. Davis, P. Davies, and P. Greengard Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline JAMA: The Journal of the American Medical Association 283 2000 1571 1577 (Pubitemid 30161512)
16. C.L. Masters, G. Simms, N.A. Weinman, G. Multhaup, B.L. McDonald, and K. Beyreuther Amyloid plaque core protein in Alzheimer disease and Down syndrome Proceedings of the National Academy of Sciences of the United States of America 82 1985 4245 4249 (Pubitemid 15053619)
17. J.A. Carson, and A.J. Turner Beta-amyloid catabolism: roles for neprilysin (NEP) and other metallopeptidases Journal of Neurochemistry 81 2002 1 8 (Pubitemid 34808849)
18. L. Morelli, A. Bulloj, M.C. Leal, and E.M. Castano Amyloid beta degradation: a challenging task for brain peptidases Sub-Cellular Biochemistry 38 2005 129 145
19. M.L. Hemming, and D.J. Selkoe Amyloid beta-protein is degraded by cellular angiotensin-converting enzyme (ACE) and elevated by an ACE inhibitor Journal of Biological Chemistry 280 2005 37644 37650 (Pubitemid 41642372)
20. J. Hu, A. Igarashi, M. Kamata, and H. Nakagawa Angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide (A beta); retards A beta aggregation, deposition, fibril formation; and inhibits cytotoxicity Journal of Biological Chemistry 276 2001 47863 47868
21. E.A. Eckman, D.K. Reed, and C.B. Eckman Degradation of the Alzheimer's amyloid beta peptide by endothelin-converting enzyme Journal of Biological Chemistry 276 2001 24540 24548
22. J.R. Backstrom, G.P. Lim, M.J. Cullen, and Z.A. Tokes Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40) Journal of Neuroscience 16 1996 7910 7919 (Pubitemid 26405054)
23. E. Savaskan, C. Hock, G. Olivieri, S. Bruttel, C. Rosenberg, and C. Hulette Cortical alterations of angiotensin converting enzyme, angiotensin II and AT1 receptor in Alzheimer's dementia Neurobiology of Aging 22 2001 541 546 (Pubitemid 32607737)
24. J.S. Miners, E. Ashby, Z. Van Helmond, K.A. Chalmers, L.E. Palmer, and S. Love Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy Neuropathology and Applied Neurobiology 34 2008 181 193 (Pubitemid 351327960)
25. S. Miners, E. Ashby, S. Baig, R. Harrison, H. Tayler, and E. Speedy Angiotensin-converting enzyme levels and activity in Alzheimer's disease: differences in brain and CSF ACE and association with ACE1 genotypes American Journal of Translational Research 1 2009 163 177
26. R. Oba, A. Igarashi, M. Kamata, K. Nagata, S. Takano, and H. Nakagawa The N-terminal active centre of human angiotensin-converting enzyme degrades Alzheimer amyloid beta-peptide European Journal of Neuroscience 21 2005 733 740 (Pubitemid 40363508)
27. J. Wang, L. Ho, L. Chen, Z. Zhao, W. Zhao, and X. Qian Valsartan lowers brain beta-amyloid protein levels and improves spatial learning in a mouse model of Alzheimer disease Journal of Clinical Investigation 117 2007 3393 3402 (Pubitemid 350096995)
28. K. Zou, H. Yamaguchi, H. Akatsu, T. Sakamoto, M. Ko, and K. Mizoguchi Angiotensin-converting enzyme converts amyloid beta-protein 1-42 (Abeta(1-42)) to Abeta(1-40), and its inhibition enhances brain Abeta deposition Journal of Neuroscience 27 2007 8628 8635 (Pubitemid 47254272)
29. J.C. de la Torre Impaired brain microcirculation may trigger Alzheimer's disease Neuroscience and Biobehavioral Reviews 18 1994 397 401 (Pubitemid 24258711)
30. R.N. Kalaria Cerebral vessels in ageing and Alzheimer's disease Pharmacology & Therapeutics 72 1996 193 214 (Pubitemid 26425810)
31. J. El Khoury, S.E. Hickman, C.A. Thomas, J.D. Loike, and S.C. Silverstein Microglia, scavenger receptors, and the pathogenesis of Alzheimer's disease Neurobiology of Aging 19 1998 S81 S84
32. L. Meda, M.A. Cassatella, G.I. Szendrei, L. Otvos Jr., P. Baron, and M. Villalba Activation of microglial cells by beta-amyloid protein and interferon-gamma Nature 374 1995 647 650
33. R.A. Santos, E.M. Krieger, and L.J. Greene An improved fluorometric assay of rat serum and plasma converting enzyme Hypertension 7 1985 244 252 (Pubitemid 15093650)
34. F. Magni, C. Sarto, C. Valsecchi, S. Casellato, S.F. Bogetto, and S. Bosari Expanding the proteome two-dimensional gel electrophoresis reference map of human renal cortex by peptide mass fingerprinting Proteomics 5 2005 816 825 (Pubitemid 40316066)
35. G. McKhann, D. Drachman, M. Folstein, R. Katzman, D. Price, and E.M. Stadlan Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of department of Health and Human Services Task Force on Alzheimer's disease Neurology 34 1984 939 944 (Pubitemid 14076461)
36. I. Bulgarelli, L. Tamiazzo, E. Bresciani, D. Rapetti, S. Caporali, and D. Lattuada Desacyl-ghrelin and synthetic GH-secretagogues modulate the production of inflammatory cytokines in mouse microglia cells stimulated by beta-amyloid fibrils Journal of Neuroscience Research 87 2009 2718 2727
37. N. Nagaya, M. Uematsu, M. Kojima, Y. Ikeda, F. Yoshihara, and W. Shimizu Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure Circulation 104 2001 1430 1435 (Pubitemid 32880158)
38. A. Tivesten, E. Bollano, K. Caidahl, V. Kujacic, X.Y. Sun, and T. Hedner The growth hormone secretagogue hexarelin improves cardiac function in rats after experimental myocardial infarction Endocrinology 141 2000 60 66 (Pubitemid 32266065)
39. S. Marleau, D. Harb, K. Bujold, R. Avallone, K. Iken, and Y. Wang EP 80317, a ligand of the CD36 scavenger receptor, protects apolipoprotein ε-deficient mice from developing atherosclerotic lesions FASEB Journal 19 2005 1869 1871 (Pubitemid 41598778)
40. S.D. Katugampola, Z. Pallikaros, and A.P. Davenport [125i-His(9)]- ghrelin, a novel radioligand for localizing GHS orphan receptors in human and rat tissue: up-regulation of receptors with atherosclerosis British Journal of Pharmacology 134 2001 143 149 (Pubitemid 32835477)
41. V. Bodart, M. Febbraio, A. Demers, N. McNicoll, P. Pohankova, and A. Perreault CD36 mediates the cardiovascular action of growth hormone-releasing peptides in the heart Circulation Research 90 2002 844 849 (Pubitemid 34633875)
42. J.M. Watermeyer, W.L. Kroger, H.G. O'Neill, B.T. Sewell, and E.D. Sturrock Characterization of domain-selective inhibitor binding in angiotensin-converting enzyme using a novel derivative of lisinopril Biochemical Journal 428 2010 67 74
43. M.D. Gahete, A. Rubio, J. Cordoba-Chacon, F. Gracia-Navarro, R.D. Kineman, and J. Avila Expression of the ghrelin and neurotensin systems is altered in the temporal lobe of Alzheimer's disease patients Journal of Alzheimer's Disease 22 2010 819 828
44. S. Diano, S.A. Farr, S.C. Benoit, E.C. McNay, I. da Silva, and B. Horvath Ghrelin controls hippocampal spine synapse density and memory performance Nature Neuroscience 9 2006 381 388 (Pubitemid 43290968)
45. T. Akamizu, K. Takaya, T. Irako, H. Hosoda, S. Teramukai, and A. Matsuyama Pharmacokinetics, safety, and endocrine and appetite effects of ghrelin administration in young healthy subjects European Journal of Endocrinology/European Federation of Endocrine Societies 150 2004 447 455 (Pubitemid 38584694)
46. C. Proto, D. Romualdi, R.M. Cento, R.S. Spada, G. Di Mento, and R. Ferri Plasma levels of neuropeptides in Alzheimer's disease Gynecological Endocrinology 22 2006 213 218
47. A. Alvarez, R. Cacabelos, C. Sanpedro, M. Garcia-Fantini, and M. Aleixandre Serum TNF-alpha levels are increased and correlate negatively with free IGF-I in Alzheimer disease Neurobiology of Aging 28 2007 533 536 (Pubitemid 46282207)
48. J.P. Jia, R. Meng, Y.X. Sun, W.J. Sun, X.M. Ji, and L.F. Jia Cerebrospinal fluid tau, Abeta1-42 and inflammatory cytokines in patients with Alzheimer's disease and vascular dementia Neuroscience Letters 383 2005 12 16 (Pubitemid 40779947)
49. G. Zuliani, M. Ranzini, G. Guerra, L. Rossi, M.R. Munari, and A. Zurlo Plasma cytokines profile in older subjects with late onset Alzheimer's disease or vascular dementia Journal of Psychiatric Research 41 2007 686 693 (Pubitemid 46498101)
50. C. Yasutake, K. Kuroda, T. Yanagawa, T. Okamura, and H. Yoneda Serum BDNF, TNF-alpha and IL-1beta levels in dementia patients: comparison between Alzheimer's disease and vascular dementia European Archives of Psychiatry and Clinical Neuroscience 256 2006 402 406 (Pubitemid 44584054)
51. E. Carro, J.L. Trejo, T. Gomez-Isla, D. LeRoith, and I. Torres-Aleman Serum insulin-like growth factor I regulates brain amyloid-beta levels Nature Medicine 8 2002 1390 1397 (Pubitemid 36019424)
52. J.J. Sevigny, J.M. Ryan, C.H. van Dyck, Y. Peng, C.R. Lines, and M.L. Nessly Growth hormone secretagogue MK-677: no clinical effect on AD progression in a randomized trial Neurology 71 2008 1702 1708